Clinical trial
Yang Yin Fu Zheng Jie Du Therapy in HBV Related Hepatocellular Carcinoma Induced Anemia
NCT05088733 is registered in ClinicalTrials.gov with Beijing Ditan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Yang Yin Fu Zheng Jie Du Therapy in HBV Related Hepatocellular Carcinoma Induced Anemia
- Lead sponsor
- Beijing Ditan Hospital
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- July 1, 2020
- Completion date
- June 30, 2023
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hepatocellular carcinoma